Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03946631 · ClinicalTrials.gov registry record
GDM Post Partum Screening
A clinical trial, sponsored by Pediatrix.
- Terminated
- Registry status
- 21
- Enrollment target
NCT03946631: Clinical Trial study, sponsored by Pediatrix.
NCT03946631 is a clinical trial that was terminated before completion, run by Pediatrix. The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03946631 was terminated before completion, sponsored by Pediatrix.
- TERMINATED
- Registry status
- 21 participants
- Enrollment target
Study Summary
Immediate postpartum screening for diabetes mellitus in women with gestational diabetes The objective of this study is to determine if screening for type 2 diabetes can be done 24 hours after delivery, versus 6-12 weeks postpartum, in recently delivered women having been diagnosed with gestational diabetes requiring medication therapy in the antecedent pregnancy.
Primary Outcome
We will compare the sensitivity of a 2-hour oral glucose tolerance test (2HR OGTT) for the detection of overt diabetes when performed within 48 hours of delivery ("early") among postpartum women previously diagnosed with gestational diabetes requiring treatment. The "early" 2HR OGTT result will be compared to the current standard of care of a 2HR OGTT performed at 6-12 weeks postpartum.
Interventions
- DIAGNOSTIC_TEST 2 hour glucose tolerance test using 75g glucose drink
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2019-08-20 |
| Est. Completion | 2022-10-21 |
Why NCT03946631 stopped before completion
NCT03946631 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 21 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which 2 hour glucose tolerance test using 75g glucose drink is the first listed.
NCT03946631 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03946631 about?
NCT03946631 is a clinical study titled "GDM Post Partum Screening". Immediate postpartum screening for diabetes mellitus in women with gestational diabetes The objective of this study is to determine if screening for type 2 diabetes can be done 24 hours after delivery, versus 6-12 weeks postpartum, in recently delivered women having been diagnosed with gestational ...
What is the current status of trial NCT03946631?
This trial is currently terminated. The enrollment target is 21 participants. The study started on 2019-08-20. Estimated completion is 2022-10-21.
What interventions are being tested in trial NCT03946631?
The interventions under investigation include: 2 hour glucose tolerance test using 75g glucose drink (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03946631?
This trial is sponsored by Pediatrix, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI